What’s the status of House lawmakers’ bill on China biotech restrictions?

BINSA, a bipartisan bill restricting US biotech deals with Chinese firms, is in limbo after failing to advance via the House Rules Committee. Sponsors include Reps. Moolenaar and Dingell.

Raccontata daendpoints.news